Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001894286 | SCV002124137 | pathogenic | Congenital dyserythropoietic anemia, type II; Cowden syndrome 7 | 2021-09-19 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg535*) in the SEC23B gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SEC23B are known to be pathogenic (PMID: 19561605, 25044164). This variant is present in population databases (rs201921350, ExAC 0.01%). This premature translational stop signal has been observed in individual(s) with congenital dyserythropoietic anemia Type II (PMID: 20941788). For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV001894286 | SCV005656386 | pathogenic | Congenital dyserythropoietic anemia, type II; Cowden syndrome 7 | 2024-05-07 | criteria provided, single submitter | clinical testing |